Previous close | 1.5200 |
Open | 1.5200 |
Bid | 1.2500 |
Ask | 1.6500 |
Strike | 20.00 |
Expiry date | 2024-01-19 |
Day's range | 1.5200 - 1.5200 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Madrigal (MDGL) is raising funds through a public offering of 1.25 million shares of its common stock to use in commercial activities in the preparation of a potential launch of resmetirom in the United States.
Acquisition news from Intercept (ICPT) and study updates from Immunovant (IMVT) are in focus in the biotech sector.
Intercept Pharmaceuticals (ICPT) gains an acquisition deal from Alfasigma for $19.00 per share in cash.